The Market Size

Venture-capital funding of gene therapy assets ($ million)

Gene therapy market size ($ billion)

Competition

Technical Advantages

  1. Developed an efficient method for constructing AdV vectors

  2. Ability to develop AdV vectors for various strains and genetically manipulate their genomes

  3. Develop hexon-chimeric AdV vectors to evade pre-existing/induced immunity

  4. Develop fiber-modified AdV vectors to alter cellular tropism

  5. Construct and try several configurations of episomal adenoviral plasmids for cell line development to produce gutless AdV vectors

Business Model

Products

Collaboration

Services

License-out

Striving to do great science

Striving to be your best partner

Let US change the world